The 200 M doses Hayat Biotech’s Life Sciences Park plant opens in Abu Dhabi

The 200 M doses Hayat Biotech’s Life Sciences Park plant opens in Abu Dhabi

- Accelerate research and development for the region

- The facility in Khalifa Economic Zone Abu Dhabi (KEZAD) is set to boost national and international drug security efforts

Abu Dhabi, UAE: - Hayat Biotech, the UAE based biotechnology leader, announced the completion of construction of its purpose-built Life Sciences Park. The state-of-the-art facility is in the Khalifa Economic Zone Abu Dhabi (KEZAD). The new plant is a research and development hub for advanced clinical research, biotechnology R&D, and vaccine and pharmaceutical production.

Hayat Biotech's flagship facility features 55,000 square meters of Greenfield production, a fully automated warehouse with a storage capacity of 72 million doses of products, a high final production capacity of 200 million doses per year, and a global distribution space. The laboratories and technical workspaces at the facility support advanced research and development capabilities to deliver world-class science and the production of innovative therapies.

Completion of the premises marks a significant milestone for Hayat Biotech's global expansion. The Life Sciences Park will solidify Abu Dhabi's position as a global frontrunner in modern medicine and research, aligned with UAE's long-term vision of building its biotechnology and life sciences capabilities.

The completion of construction ceremony of Life Sciences Park was held in the presence